We are live on ! Find out more
IRMD icon

iRadimed

162 hedge funds and large institutions have $422M invested in iRadimed in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 63 increasing their positions, 53 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 53

15% more capital invested

Capital invested by funds: $365M → $422M (+$56.3M)

0.73% more ownership

Funds ownership: 54.73%55.46% (+0.73%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less funds holding

Funds holding: 168162 (-6)

30% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 20

86% less call options, than puts

Call options by funds: $36K | Put options by funds: $251K

Holders
162
Holders Change
-6
Holders Change %
-3.57%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
14
Increased
63
Reduced
53
Closed
20
Calls
$36K
Puts
$251K
Net Calls
-$215K
Net Calls Change
-$53K
Name Holding Trade Value Shares
Change
Change in
Stake
QT
176
Quantbot Technologies
New York
-$78K -1,486 Closed
Simplex Trading
177
Simplex Trading
Illinois
-$47K -907 Closed
AS
178
Altshuler Shaham
Israel
-$3.78K -72 Closed
CPG
179
Cornerstone Planning Group
New Jersey
-$3.27K -62 Closed
BIG
180
Brooklyn Investment Group
New York
-$2.62K -50 Closed
CCM
181
Coldstream Capital Management
Washington
-$420 -8 Closed
MAS
182
MPWM Advisory Solutions
Georgia
-$367 -7 Closed

IRMD Hedge Fund Activity: Q2 2025 in Review

162 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2025, worth a combined $422M — up 15% from $365M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of IRMD and 14 opened new positions — a net loss of 6 holders — while 53 trimmed existing stakes and 63 added.

The largest buyer was Millennium Management, adding an estimated $2.27M. The largest seller was Copeland Capital Management, cutting an estimated $1.79M.

  • 162 institutional investors held iRadimed (IRMD) as of Q2 2025, down from 168 in Q1 2025.
  • Funds reported $422M of iRadimed stock for Q2 2025, up 15% quarter-over-quarter.
  • 14 funds opened new iRadimed positions in Q2 2025 and 20 closed out, a net change of -6 holders.
  • The largest iRadimed buyer in Q2 2025 was Millennium Management, an estimated $2.27M added.
  • The largest iRadimed seller in Q2 2025 was Copeland Capital Management, an estimated $1.79M sold.

Based on aggregated 13F filings for Q2 2025.